BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18468893)

  • 1. Improved synthesis of antibacterial 3-substituted 6-anilinouracils.
    Svenstrup N; Kuhl A; Ehlert K; Häbich D
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3215-8. PubMed ID: 18468893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth.
    Zhi C; Long ZY; Gambino J; Xu WC; Brown NC; Barnes M; Butler M; LaMarr W; Wright GE
    J Med Chem; 2003 Jun; 46(13):2731-9. PubMed ID: 12801236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of 3-substituted-6-(3-ethyl-4-methylanilino)uracils.
    Zhi C; Long ZY; Manikowski A; Brown NC; Tarantino PM; Holm K; Dix EJ; Wright GE; Foster KA; Butler MM; LaMarr WA; Skow DJ; Motorina I; Lamothe S; Storer R
    J Med Chem; 2005 Nov; 48(22):7063-74. PubMed ID: 16250666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3.
    Tarantino PM; Zhi C; Gambino JJ; Wright GE; Brown NC
    J Med Chem; 1999 Jun; 42(11):2035-40. PubMed ID: 10354411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.
    Zhi C; Long ZY; Manikowski A; Comstock J; Xu WC; Brown NC; Tarantino PM; Holm KA; Dix EJ; Wright GE; Barnes MH; Butler MM; Foster KA; LaMarr WA; Bachand B; Bethell R; Cadilhac C; Charron S; Lamothe S; Motorina I; Storer R
    J Med Chem; 2006 Feb; 49(4):1455-65. PubMed ID: 16480282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphlococcus aureus DNA polymerase III: design, synthesis, and biological evaluation.
    Ali A; Taylor GE; Ellsworth K; Harris G; Painter R; Silver LL; Young K
    J Med Chem; 2003 May; 46(10):1824-30. PubMed ID: 12723946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzyme.
    Kuhl A; Svenstrup N; Ladel C; Otteneder M; Binas A; Schiffer G; Brands M; Lampe T; Ziegelbauer K; Rübsamen-Waigmann H; Haebich D; Ehlert K
    Antimicrob Agents Chemother; 2005 Mar; 49(3):987-95. PubMed ID: 15728893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New DNA polymerase IIIC inhibitors: 3-subtituted anilinouracils with potent antibacterial activity in vitro and in vivo.
    Svenstrup N; Ehlert K; Ladel C; Kuhl A; Häbich D
    ChemMedChem; 2008 Oct; 3(10):1604-15. PubMed ID: 18792034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.
    Tarantino PM; Zhi C; Wright GE; Brown NC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1982-7. PubMed ID: 10428923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III.
    Ali A; Aster SD; Graham DW; Patel GF; Taylor GE; Tolman RL; Painter RE; Silver LL; Young K; Ellsworth K; Geissler W; Harris GS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2185-8. PubMed ID: 11514166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
    Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
    Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.
    Daly JS; Giehl TJ; Brown NC; Zhi C; Wright GE; Ellison RT
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2217-21. PubMed ID: 10898708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC.
    Rose Y; Ciblat S; Reddy R; Belley AC; Dietrich E; Lehoux D; McKay GA; Poirier H; Far AR; Delorme D
    Bioorg Med Chem Lett; 2006 Feb; 16(4):891-6. PubMed ID: 16298129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
    Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
    J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site directed inhibitors of replication-specific bacterial DNA polymerases.
    Wright GE; Brown NC; Xu WC; Long ZY; Zhi C; Gambino JJ; Barnes MH; Butler MM
    Bioorg Med Chem Lett; 2005 Feb; 15(3):729-32. PubMed ID: 15664846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agents.
    Vara Prasad JV; Boyer FE; Chupak L; Dermyer M; Ding Q; Gavardinas K; Hagen SE; Huband MD; Jiao W; Kaneko T; Maiti SN; Melnick M; Romero K; Patterson M; Wu X
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5392-7. PubMed ID: 16901693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
    Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
    Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of 9-substituted minocycline derivatives.
    Sum PE; Ross AT; Petersen PJ; Testa RT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):400-3. PubMed ID: 16246559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.